A university researcher is suggesting the agency redo a core component of its risk analysis for methylene chloride, which causes non-cancer effects to the nervous system, in a way that it usually assesses cancer risks -- an approach that could bolster any cost-benefit analysis the agency conducts to justify its upcoming risk management rules under TSCA.